The role of molecular analyses in the era of personalized therapy for advanced NSCLC-Reference-Cited by-同舟云学术

The role of molecular analyses in the era of personalized therapy for advanced NSCLC

Published:2012-05 Issue:2 Volume:76 Page:131-137
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Tanner Nichole T.,Pastis Nicholas J.,Sherman Carol,Simon George R.,Lewin David,Silvestri Gerard A.

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference59 articles.

1. American Cancer Society. Cancer facts & figures, 2010. Atlanta, GA: American Cancer Society; 2010.

2. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology™. Non-small cell lung cancer. V.3.2011. http://www.nccn.org/professionals/physician_gls/PDF/nscl.pdf [accessed May 21, 11 A.D].

3. Epidermal growth factor receptor expression, signal pathway, and inhibitors in non-small cell lung cancer;Bunn;Semin Oncol,2002

4. Personalized medicine and inhibition of EGFR signaling in lung cancer;Gazdar;N Engl J Med,2009

5. Targeted therapy for the treatment of advanced non-small cell lung cancer: a review of the epidermal growth factor receptor antagonists;Silvestri;Chest,2005

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Experiencia inicial de detección de mutaciones en biopsia tumoral y líquida de pacientes con adenocarcinoma pulmonar;Revista Médica Clínica Las Condes;2022-01

2. Molecular testing and treatment patterns for patients with advanced non-small cell lung cancer: PIvOTAL observational study;PLOS ONE;2018-08-27

3. Intrapleural targeted therapies (anti-VEGF and anti-EGFR) in the model of malignant pleural effusion;Oncotarget;2017-09-28

4. MiR-661 promotes tumor invasion and metastasis by directly inhibiting RB1 in non small cell lung cancer;Molecular Cancer;2017-07-17

5. Molecular markers in lung cancer;Current Opinion in Pulmonary Medicine;2017-05